GSK Expands Portfolio of Asthma/COPD Medicines in U.S. – Drug Discovery & Development


Monthly Prescribing Reference

GSK Expands Portfolio of Asthma/COPD Medicines in U.S.
Drug Discovery & Development
GlaxoSmithKline plc announced the simultaneous availability of two of its recently approved products for the treatment of asthma and COPD to retail pharmacies in the US. Over the past 15 months, GSK has launched four inhaled respiratory therapies in
GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPDRTT News
New Inhalers for Asthma, COPD LaunchedMonthly Prescribing Reference
GSK expands its portfolio of medicines in the US for patients with asthma and SYS-CON Media (press release)

all 5 news articles »

View full post on asthma – Google News

GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPD – RTT News


Monthly Prescribing Reference

GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPD
RTT News
Arnuity Ellipta (fluticasone furoate inhalation powder) is a once-daily inhaled corticosteroid (ICS) medicine for the maintenance treatment of asthma. It is the first product in the Ellipta inhaler for the treatment of asthma to be introduced in the US
New Inhalers for Asthma, COPD LaunchedMonthly Prescribing Reference
GSK Expands Portfolio of Asthma/COPD Medicines in U.S.Drug Discovery & Development
GSK expands its portfolio of medicines in the US for patients with asthma and SYS-CON Media (press release)

all 6 news articles »

View full post on asthma – Google News

GSK Expands Its Asthma and COPD Portfolio in the US – Pharmaceutical Processing


SYS-CON Media

GSK Expands Its Asthma and COPD Portfolio in the US
Pharmaceutical Processing
GlaxoSmithKline has announced the simultaneous availability of two of its recently approved products for the treatment of asthma and COPD to retail pharmacies in the US. Over the past 15 months, GSK has launched four inhaled respiratory therapies in
GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPDRTT News
GSK expands its portfolio of medicines in the US for patients with asthma and MarketWatch

all 4 news articles »

View full post on asthma – Google News